Long	O
-	O
term	O
cardiovascular	O
mortality	O
after	O
radiotherapy	B:C0085203
for	O
breast	O
cancer	I:C0006142
:	O
A	O
systematic	O
review	I:C1955832
and	O
meta-analysis	O
.	O

Long	O
-	O
term	O
cardiovascular	O
mortality	O
after	O
radiotherapy	O
for	O
breast	B:C0006142
cancer	I:C0006142
:	O
A	O
systematic	O
review	I:C1955832
and	O
meta-analysis	O
.	O

Long	O
-	O
term	O
cardiovascular	O
mortality	O
after	O
radiotherapy	O
for	O
breast	O
cancer	I:C0006142
:	O
A	O
systematic	B:C1955832
review	I:C1955832
and	O
meta-analysis	O
.	O

Long	O
-	O
term	O
cardiovascular	O
mortality	O
after	O
radiotherapy	O
for	O
breast	O
cancer	I:C0006142
:	O
A	O
systematic	O
review	I:C1955832
and	O
meta-analysis	B:C0920317
.	O

Radiotherapy	B:C0085203
(	O
Radiotherapy	O
)	O
is	O
frequently	O
associated	O
with	O
late	O
cardiovascular	O
(	I:C0161816
CV	I:C0161816
)	I:C0161816
complications	I:C0161816
.	O

Radiotherapy	O
(	O
Radiotherapy	B:C0085203
)	O
is	O
frequently	O
associated	O
with	O
late	O
cardiovascular	O
(	I:C0161816
CV	I:C0161816
)	I:C0161816
complications	I:C0161816
.	O

Radiotherapy	O
(	O
Radiotherapy	O
)	O
is	O
frequently	O
associated	O
with	O
late	O
cardiovascular	B:C0161816
(	I:C0161816
CV	I:C0161816
)	I:C0161816
complications	I:C0161816
.	O

The	O
mean	O
cardiac	O
dose	O
from	O
irradiation	O
of	O
a	O
left	B:C4042788
-	I:C4042788
sided	I:C4042788
breast	I:C4042788
cancer	I:C4042788
is	O
much	O
higher	O
than	O
that	O
for	O
a	O
right	O
-	I:C4042789
sided	I:C4042789
breast	I:C4042789
cancer	I:C4042789
.	O

The	O
mean	O
cardiac	O
dose	O
from	O
irradiation	O
of	O
a	O
left	O
-	I:C4042788
sided	I:C4042788
breast	I:C4042788
cancer	I:C4042788
is	O
much	O
higher	O
than	O
that	O
for	O
a	O
right	B:C4042789
-	I:C4042789
sided	I:C4042789
breast	I:C4042789
cancer	I:C4042789
.	O

However	O
,	O
data	O
is	O
limited	O
on	O
the	O
long	O
-	O
term	O
risks	O
of	O
Radiotherapy	B:C0085203
on	O
CV	O
mortality	O
.	O

Radiotherapy	B:C0085203
for	O
breast	O
cancer	I:C0006142
is	O
associated	O
with	O
long	O
term	O
CV	O
mortality	O
and	O
left	O
sided	I:C0443246
Radiotherapy	O
carries	O
a	O
greater	O
mortality	O
than	O
right	O
sided	I:C0444532
Radiotherapy	O
.	O

Radiotherapy	O
for	O
breast	B:C0006142
cancer	I:C0006142
is	O
associated	O
with	O
long	O
term	O
CV	O
mortality	O
and	O
left	O
sided	I:C0443246
Radiotherapy	O
carries	O
a	O
greater	O
mortality	O
than	O
right	O
sided	I:C0444532
Radiotherapy	O
.	O

Radiotherapy	O
for	O
breast	O
cancer	I:C0006142
is	O
associated	O
with	O
long	O
term	O
CV	O
mortality	O
and	O
left	B:C0443246
sided	I:C0443246
Radiotherapy	O
carries	O
a	O
greater	O
mortality	O
than	O
right	O
sided	I:C0444532
Radiotherapy	O
.	O

Radiotherapy	O
for	O
breast	O
cancer	I:C0006142
is	O
associated	O
with	O
long	O
term	O
CV	O
mortality	O
and	O
left	O
sided	I:C0443246
Radiotherapy	B:C0085203
carries	O
a	O
greater	O
mortality	O
than	O
right	O
sided	I:C0444532
Radiotherapy	O
.	O

Radiotherapy	O
for	O
breast	O
cancer	I:C0006142
is	O
associated	O
with	O
long	O
term	O
CV	O
mortality	O
and	O
left	O
sided	I:C0443246
Radiotherapy	O
carries	O
a	O
greater	O
mortality	O
than	O
right	B:C0444532
sided	I:C0444532
Radiotherapy	O
.	O

Radiotherapy	O
for	O
breast	O
cancer	I:C0006142
is	O
associated	O
with	O
long	O
term	O
CV	O
mortality	O
and	O
left	O
sided	I:C0443246
Radiotherapy	O
carries	O
a	O
greater	O
mortality	O
than	O
right	O
sided	I:C0444532
Radiotherapy	B:C0085203
.	O

We	O
searched	O
PubMed	B:C1138432
,	O
Cochrane	O
Central	I:C0242356
,	O
Embase	O
,	O
EBSCO	O
,	O
Web	O
of	I:C0242356
Science	I:C0242356
,	O
and	O
CINAHL	O
databases	I:C0242356
from	O
inception	O
through	O
December	O
2015	O
.	O

We	O
searched	O
PubMed	O
,	O
Cochrane	B:C0242356
Central	I:C0242356
,	O
Embase	O
,	O
EBSCO	O
,	O
Web	O
of	I:C0242356
Science	I:C0242356
,	O
and	O
CINAHL	O
databases	I:C0242356
from	O
inception	O
through	O
December	O
2015	O
.	O

We	O
searched	O
PubMed	O
,	O
Cochrane	O
Central	I:C0242356
,	O
Embase	B:C0242356
,	O
EBSCO	O
,	O
Web	O
of	I:C0242356
Science	I:C0242356
,	O
and	O
CINAHL	O
databases	I:C0242356
from	O
inception	O
through	O
December	O
2015	O
.	O

We	O
searched	O
PubMed	O
,	O
Cochrane	O
Central	I:C0242356
,	O
Embase	O
,	O
EBSCO	B:C0242356
,	O
Web	O
of	I:C0242356
Science	I:C0242356
,	O
and	O
CINAHL	O
databases	I:C0242356
from	O
inception	O
through	O
December	O
2015	O
.	O

We	O
searched	O
PubMed	O
,	O
Cochrane	O
Central	I:C0242356
,	O
Embase	O
,	O
EBSCO	O
,	O
Web	B:C0242356
of	I:C0242356
Science	I:C0242356
,	O
and	O
CINAHL	O
databases	I:C0242356
from	O
inception	O
through	O
December	O
2015	O
.	O

We	O
searched	O
PubMed	O
,	O
Cochrane	O
Central	I:C0242356
,	O
Embase	O
,	O
EBSCO	O
,	O
Web	O
of	I:C0242356
Science	I:C0242356
,	O
and	O
CINAHL	B:C0242356
databases	I:C0242356
from	O
inception	O
through	O
December	O
2015	O
.	O

Studies	O
reporting	B:C0700287
CV	O
mortality	O
with	O
Radiotherapy	O
for	O
left	O
-	I:C4042788
vs	O
right	O
-	I:C4042789
sided	I:C4042789
breast	I:C4042789
cancers	I:C4042789
were	O
included	O
.	O

Studies	O
reporting	O
CV	O
mortality	O
with	O
Radiotherapy	B:C0085203
for	O
left	O
-	I:C4042788
vs	O
right	O
-	I:C4042789
sided	I:C4042789
breast	I:C4042789
cancers	I:C4042789
were	O
included	O
.	O

Studies	O
reporting	O
CV	O
mortality	O
with	O
Radiotherapy	O
for	O
left	B:C4042788
-	I:C4042788
vs	O
right	O
-	I:C4042789
sided	I:C4042789
breast	I:C4042789
cancers	I:C4042789
were	O
included	O
.	O

Studies	O
reporting	O
CV	O
mortality	O
with	O
Radiotherapy	O
for	O
left	O
-	I:C4042788
vs	O
right	B:C4042789
-	I:C4042789
sided	I:C4042789
breast	I:C4042789
cancers	I:C4042789
were	O
included	O
.	O

The	O
analysis	B:C0936012
included	O
289	O
109	O
patients	O
from	O
13	O
observational	O
studies	I:C1518527
.	O

The	O
analysis	O
included	O
289	O
109	O
patients	O
from	O
13	O
observational	B:C1518527
studies	I:C1518527
.	O

Women	B:C0043210
who	O
had	O
received	O
Radiotherapy	O
for	O
left	O
-	I:C4042788
sided	I:C4042788
breast	I:C4042788
cancer	I:C4042788
had	O
a	O
higher	O
risk	O
of	O
CV	O
death	O
than	O
those	O
who	O
received	O
Radiotherapy	O
for	O
a	O
right	O
-	I:C4042789
sided	I:C4042789
breast	I:C4042789
cancer	I:C4042789
(	O
RR	O
:	O
1.12	O
,	O
95	O
%	O
CI	O
:	O
1.07	O
-	O
1.18	O
,	O
P	O
<	O
0.001	O
;	O
number	O
needed	O
to	O
harm	O
:	O
353	O
)	O
.	O

Women	O
who	O
had	O
received	O
Radiotherapy	B:C0085203
for	O
left	O
-	I:C4042788
sided	I:C4042788
breast	I:C4042788
cancer	I:C4042788
had	O
a	O
higher	O
risk	O
of	O
CV	O
death	O
than	O
those	O
who	O
received	O
Radiotherapy	O
for	O
a	O
right	O
-	I:C4042789
sided	I:C4042789
breast	I:C4042789
cancer	I:C4042789
(	O
RR	O
:	O
1.12	O
,	O
95	O
%	O
CI	O
:	O
1.07	O
-	O
1.18	O
,	O
P	O
<	O
0.001	O
;	O
number	O
needed	O
to	O
harm	O
:	O
353	O
)	O
.	O

Women	O
who	O
had	O
received	O
Radiotherapy	O
for	O
left	B:C4042788
-	I:C4042788
sided	I:C4042788
breast	I:C4042788
cancer	I:C4042788
had	O
a	O
higher	O
risk	O
of	O
CV	O
death	O
than	O
those	O
who	O
received	O
Radiotherapy	O
for	O
a	O
right	O
-	I:C4042789
sided	I:C4042789
breast	I:C4042789
cancer	I:C4042789
(	O
RR	O
:	O
1.12	O
,	O
95	O
%	O
CI	O
:	O
1.07	O
-	O
1.18	O
,	O
P	O
<	O
0.001	O
;	O
number	O
needed	O
to	O
harm	O
:	O
353	O
)	O
.	O

Women	O
who	O
had	O
received	O
Radiotherapy	O
for	O
left	O
-	I:C4042788
sided	I:C4042788
breast	I:C4042788
cancer	I:C4042788
had	O
a	O
higher	O
risk	O
of	O
CV	O
death	O
than	O
those	O
who	O
received	O
Radiotherapy	B:C0085203
for	O
a	O
right	O
-	I:C4042789
sided	I:C4042789
breast	I:C4042789
cancer	I:C4042789
(	O
RR	O
:	O
1.12	O
,	O
95	O
%	O
CI	O
:	O
1.07	O
-	O
1.18	O
,	O
P	O
<	O
0.001	O
;	O
number	O
needed	O
to	O
harm	O
:	O
353	O
)	O
.	O

Women	O
who	O
had	O
received	O
Radiotherapy	O
for	O
left	O
-	I:C4042788
sided	I:C4042788
breast	I:C4042788
cancer	I:C4042788
had	O
a	O
higher	O
risk	O
of	O
CV	O
death	O
than	O
those	O
who	O
received	O
Radiotherapy	O
for	O
a	O
right	B:C4042789
-	I:C4042789
sided	I:C4042789
breast	I:C4042789
cancer	I:C4042789
(	O
RR	O
:	O
1.12	O
,	O
95	O
%	O
CI	O
:	O
1.07	O
-	O
1.18	O
,	O
P	O
<	O
0.001	O
;	O
number	O
needed	O
to	O
harm	O
:	O
353	O
)	O
.	O

Difference	O
in	O
CV	O
mortality	O
between	O
left	B:C0443246
-	I:C0443246
vs	O
right	O
-	I:C0444532
sided	I:C0444532
breast	O
Radiotherapy	O
was	O
more	O
apparent	O
after	O
15	O
years	O
of	O
follow	O
-	I:C1522577
up	I:C1522577
(	O
RR	O
:	O
1.23	O
,	O
95	O
%	O
CI	O
:	O
1.08	O
-	O
1.41	O
,	O
P	O
<	O
0.001	O
;	O
number	O
needed	O
to	O
harm	O
:	O
95	O
)	O
.	O

Difference	O
in	O
CV	O
mortality	O
between	O
left	O
-	I:C0443246
vs	O
right	B:C0444532
-	I:C0444532
sided	I:C0444532
breast	O
Radiotherapy	O
was	O
more	O
apparent	O
after	O
15	O
years	O
of	O
follow	O
-	I:C1522577
up	I:C1522577
(	O
RR	O
:	O
1.23	O
,	O
95	O
%	O
CI	O
:	O
1.08	O
-	O
1.41	O
,	O
P	O
<	O
0.001	O
;	O
number	O
needed	O
to	O
harm	O
:	O
95	O
)	O
.	O

Difference	O
in	O
CV	O
mortality	O
between	O
left	O
-	I:C0443246
vs	O
right	O
-	I:C0444532
sided	I:C0444532
breast	B:C0006141
Radiotherapy	O
was	O
more	O
apparent	O
after	O
15	O
years	O
of	O
follow	O
-	I:C1522577
up	I:C1522577
(	O
RR	O
:	O
1.23	O
,	O
95	O
%	O
CI	O
:	O
1.08	O
-	O
1.41	O
,	O
P	O
<	O
0.001	O
;	O
number	O
needed	O
to	O
harm	O
:	O
95	O
)	O
.	O

Difference	O
in	O
CV	O
mortality	O
between	O
left	O
-	I:C0443246
vs	O
right	O
-	I:C0444532
sided	I:C0444532
breast	O
Radiotherapy	B:C0085203
was	O
more	O
apparent	O
after	O
15	O
years	O
of	O
follow	O
-	I:C1522577
up	I:C1522577
(	O
RR	O
:	O
1.23	O
,	O
95	O
%	O
CI	O
:	O
1.08	O
-	O
1.41	O
,	O
P	O
<	O
0.001	O
;	O
number	O
needed	O
to	O
harm	O
:	O
95	O
)	O
.	O

Difference	O
in	O
CV	O
mortality	O
between	O
left	O
-	I:C0443246
vs	O
right	O
-	I:C0444532
sided	I:C0444532
breast	O
Radiotherapy	O
was	O
more	O
apparent	O
after	O
15	O
years	O
of	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
(	O
RR	O
:	O
1.23	O
,	O
95	O
%	O
CI	O
:	O
1.08	O
-	O
1.41	O
,	O
P	O
<	O
0.001	O
;	O
number	O
needed	O
to	O
harm	O
:	O
95	O
)	O
.	O

CV	O
mortality	O
from	O
left	B:C0443246
-	I:C0443246
sided	I:C0443246
Radiotherapy	O
was	O
significantly	O
higher	O
compared	O
with	O
right	O
-	I:C0444532
sided	I:C0444532
Radiotherapy	O
for	O
breast	O
cancer	I:C0006142
and	O
was	O
more	O
apparent	O
after	O
≥	O
15	O
years	O
of	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

CV	O
mortality	O
from	O
left	O
-	I:C0443246
sided	I:C0443246
Radiotherapy	B:C0085203
was	O
significantly	O
higher	O
compared	O
with	O
right	O
-	I:C0444532
sided	I:C0444532
Radiotherapy	O
for	O
breast	O
cancer	I:C0006142
and	O
was	O
more	O
apparent	O
after	O
≥	O
15	O
years	O
of	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

CV	O
mortality	O
from	O
left	O
-	I:C0443246
sided	I:C0443246
Radiotherapy	O
was	O
significantly	O
higher	O
compared	O
with	O
right	B:C0444532
-	I:C0444532
sided	I:C0444532
Radiotherapy	O
for	O
breast	O
cancer	I:C0006142
and	O
was	O
more	O
apparent	O
after	O
≥	O
15	O
years	O
of	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

CV	O
mortality	O
from	O
left	O
-	I:C0443246
sided	I:C0443246
Radiotherapy	O
was	O
significantly	O
higher	O
compared	O
with	O
right	O
-	I:C0444532
sided	I:C0444532
Radiotherapy	B:C0085203
for	O
breast	O
cancer	I:C0006142
and	O
was	O
more	O
apparent	O
after	O
≥	O
15	O
years	O
of	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

CV	O
mortality	O
from	O
left	O
-	I:C0443246
sided	I:C0443246
Radiotherapy	O
was	O
significantly	O
higher	O
compared	O
with	O
right	O
-	I:C0444532
sided	I:C0444532
Radiotherapy	O
for	O
breast	B:C0006142
cancer	I:C0006142
and	O
was	O
more	O
apparent	O
after	O
≥	O
15	O
years	O
of	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

CV	O
mortality	O
from	O
left	O
-	I:C0443246
sided	I:C0443246
Radiotherapy	O
was	O
significantly	O
higher	O
compared	O
with	O
right	O
-	I:C0444532
sided	I:C0444532
Radiotherapy	O
for	O
breast	O
cancer	I:C0006142
and	O
was	O
more	O
apparent	O
after	O
≥	O
15	O
years	O
of	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
.	O

